CD4 and inflammatory bowel disease: In line with the fact that the microbiota can be involved in the pathogenesis of IBD, colonic-resident CD4+ T cells reactive to enteric bacteria presented increased IL-17A production in both CD and UC patients regardless of disease activity or therapy [11].